-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Maintains Buy on BioHarvest Sciences, Lowers Price Target to $5

Benzinga·08/12/2026 18:30:33
Listen to the news
Maxim Group analyst Anthony Vendetti maintains BioHarvest Sciences (NASDAQ:BHST) with a Buy and lowers the price target from $12 to $5.